Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vilaprisan (BAY 1002670) is a novel orally available and selective progesterone receptor modulator (SPRM) with antiproliferative activity against uterine fibroids (UF) and can be used for the study of uterine fibroids.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 465.00 | |
10 mg | In stock | $ 679.00 | |
25 mg | In stock | $ 1,070.00 | |
50 mg | In stock | $ 1,430.00 | |
100 mg | In stock | $ 1,930.00 |
Description | Vilaprisan (BAY 1002670) is a novel orally available and selective progesterone receptor modulator (SPRM) with antiproliferative activity against uterine fibroids (UF) and can be used for the study of uterine fibroids. |
In vitro | Vilaprisan shows an IC50 of 0.09 nM in the PR transactivation assay[2]. |
Synonyms | BAY 1002670, BAY10-02670, BAY-1002670, BAY1002670, BAY-10-02670, BAY 10-02670 |
Molecular Weight | 544.57 |
Formula | C27H29F5O4S |
CAS No. | 1262108-14-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.86 mg/mL (14.43 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vilaprisan 1262108-14-4 Others Progesterone Receptor BAY 1002670 BAY10-02670 BAY-1002670 BAY1002670 BAY-10-02670 BAY 10-02670 inhibitor inhibit